Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies  Edward J. Bergeron, MD, Jules Lin, MD, Andrew C. Chang, MD, Mark B. Orringer, MD, Rishindra M. Reddy, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 147, Issue 2, Pages 765-773 (February 2014) DOI: 10.1016/j.jtcvs.2013.10.003 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Prevalence of metastatic pathologic nodes based on pathologic tumor depth. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 765-773DOI: (10.1016/j.jtcvs.2013.10.003) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Prevalence of metastatic lymph nodes in EUS early-stage cT0-cT1 esophageal tumors: EUS cN versus esophagectomy pN. EUS, Endoscopic ultrasound. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 765-773DOI: (10.1016/j.jtcvs.2013.10.003) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions